Jiangning Gu

703 total citations
29 papers, 515 citations indexed

About

Jiangning Gu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jiangning Gu has authored 29 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Jiangning Gu's work include Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Jiangning Gu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Jiangning Gu collaborates with scholars based in China, Germany and Australia. Jiangning Gu's co-authors include Chenghong Peng, Hao Chen, Minmin Shi, Baiyong Shen, Haifeng Luo, Jiaqiang Zhang, Changyuan Wang, Qiang Meng, Jingjing Wu and Yi Zhu and has published in prestigious journals such as Free Radical Biology and Medicine, Cancer Letters and Medicine.

In The Last Decade

Jiangning Gu

27 papers receiving 509 citations

Peers

Jiangning Gu
Yuanbiao Guo China
Jichao Wei China
Weili Min China
Chao Wu China
Hao Shi China
Jin Gao China
Laura Ruíz-Cañas Spain
Yuting Wu China
Juji Dai China
Yuanbiao Guo China
Jiangning Gu
Citations per year, relative to Jiangning Gu Jiangning Gu (= 1×) peers Yuanbiao Guo

Countries citing papers authored by Jiangning Gu

Since Specialization
Citations

This map shows the geographic impact of Jiangning Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangning Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangning Gu more than expected).

Fields of papers citing papers by Jiangning Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangning Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangning Gu. The network helps show where Jiangning Gu may publish in the future.

Co-authorship network of co-authors of Jiangning Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangning Gu. A scholar is included among the top collaborators of Jiangning Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangning Gu. Jiangning Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Jian, Tong Shen, Dan Chen, et al.. (2025). FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer. Cell Biochemistry and Biophysics. 83(2). 2441–2452. 2 indexed citations
2.
3.
Zhang, Di, Tong Shen, Feng Gao, et al.. (2025). Endoscopic treatment of unresectable perihilar cholangiocarcinoma: beyond biliary drainage. Therapeutic Advances in Gastroenterology. 18. 1128511571–1128511571.
4.
Lin, Li, Wenyu Wang, Xia Li, et al.. (2024). Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR. Phytomedicine. 130. 155693–155693. 13 indexed citations
5.
6.
Li, Lin, Lina Kong, Changyuan Wang, et al.. (2024). FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease. Hepatology International. 18(1). 188–205. 9 indexed citations
7.
Xu, Shuai, Lina Kong, Lin Li, et al.. (2023). Farnesoid X receptor overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in nonalcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(2). 166930–166930. 4 indexed citations
8.
Gu, Jiangning, Bin Fan, Haoran Li, et al.. (2022). Efficacy and complications of inoperable malignant distal biliary obstruction treatment by metallic stents: fully covered or uncovered?. Gastroenterology report. 11. goad048–goad048. 1 indexed citations
9.
Gu, Jiangning, Haifeng Luo, Guang Tan, et al.. (2022). ORM 1 as a biomarker of increased vascular invasion and decreased sorafenib sensitivity in hepatocellular carcinoma. Bosnian Journal of Basic Medical Sciences. 22(6). 949–958. 11 indexed citations
10.
Tan, Guang, Jie Zhang, Bin Fan, et al.. (2022). Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?. Frontiers in Oncology. 12. 828223–828223. 5 indexed citations
11.
Kong, Lina, Kai Huang, Xiaohui Wang, et al.. (2021). Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR. Phytomedicine. 90. 153629–153629. 30 indexed citations
12.
Wen, Chenlei, Xiaxing Deng, Song Xue, et al.. (2020). Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma. Cancer Medicine. 9(20). 7626–7636. 2 indexed citations
13.
Gu, Jiangning, Zhiwei Xu, Yang Ma, et al.. (2020). Surgical resection of metastatic pancreatic cancer: is it worth it?—a 15-year experience at a single Chinese center. Journal of Gastrointestinal Oncology. 11(2). 319–328. 8 indexed citations
14.
Zhang, Zhiqiang, Jiangning Gu, Di Wang, et al.. (2020). Establishment and Investigation of a Multiple Gene Expression Signature to Predict Long‐Term Survival in Pancreatic Cancer. BioMed Research International. 2020(1). 1570862–1570862. 1 indexed citations
15.
Walter, Karolin, Marija Trajkovic‐Arsic, Ana Hidalgo‐Sastre, et al.. (2019). MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer CellsIn VitroandIn Vivo. Stem Cells International. 2019. 1–11. 12 indexed citations
16.
Ma, Yang, Yiran Zhou, Xiayang Ying, et al.. (2019). Resection of pancreatic metastatic renal cell carcinoma: experience and long-term survival outcome from a large center in China. International Journal of Clinical Oncology. 24(6). 686–693. 12 indexed citations
17.
Gu, Jiangning, Wei Xu, Chenghong Peng, et al.. (2019). Perineural invasion is related to p38 mitogen‐activated protein kinase pathway activation and promotes tumor growth and chemoresistance in pancreatic cancer. Journal of Cellular Biochemistry. 120(7). 11775–11783. 4 indexed citations
18.
Li, Yuanyuan, Jiaqiang Zhang, Jiangning Gu, & Shi Chen. (2017). Biosynthesis of polyphenol-stabilised nanoparticles and assessment of anti-diabetic activity. Journal of Photochemistry and Photobiology B Biology. 169. 96–100. 17 indexed citations
19.
Zhu, Youwei, Jiangning Gu, Ying Li, et al.. (2017). MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes. Cancer Letters. 412. 59–68. 80 indexed citations
20.
Gu, Jiangning, Di Wang, Jiaqiang Zhang, et al.. (2016). GFRα2 prompts cell growth and chemoresistance through down-regulating tumor suppressor gene PTEN via Mir-17-5p in pancreatic cancer. Cancer Letters. 380(2). 434–441. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuanbiao Guo Breakdown of academic impact, for papers by Jichao Wei Breakdown of academic impact, for papers by Weili Min Breakdown of academic impact, for papers by Chao Wu Breakdown of academic impact, for papers by Hao Shi Breakdown of academic impact, for papers by Jin Gao Breakdown of academic impact, for papers by Laura Ruíz-Cañas Breakdown of academic impact, for papers by Yuting Wu Breakdown of academic impact, for papers by Juji Dai
Rankless by CCL
2026